Cellectis

CLLSNasdaq France Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$284.995 M

$2.84 +5.39%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#240Jupiter NeurosciencesJUNS$288.3M
#241Natures Sunshine ProductsNATR$288.0M
#242CellectisCLLS$285.0M
#243Eledon PharmaceuticalsELDN$284.8M
#244Alx OncologyALXO$282.6M

Where these numbers come from

Share counts and financials for Cellectis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.